Ruxolitinib Phosphate: Selective JAK-STAT Inhibition in T...
2025-10-18
Ruxolitinib phosphate (INCB018424) is redefining how researchers interrogate the JAK/STAT pathway across autoimmune, inflammatory, and oncologic models. This article delivers a bench-to-publication roadmap, highlighting advanced workflows, troubleshooting strategies, and emerging use-cases that maximize experimental impact.